A robust prognostic signature for hormone-positive node-negative breast cancer

被引：0
|
作者：
Obi L Griffith
François Pepin
Oana M Enache
Laura M Heiser
Eric A Collisson
Paul T Spellman
Joe W Gray
机构：
[1] Lawrence Berkeley National Laboratory,Department of Cancer and DNA Damage Responses, Life Sciences Division
[2] The Genome Institute,Department of Medicine, Division of Oncology
[3] Washington University,Department of Biomedical Engineering
[4] Sequenta Inc.,Division of Hematology/Oncology
[5] Center for Spatial Systems Biomedicine,Department of Molecular and Medical Genetics
[6] Knight Cancer Institute,undefined
[7] Oregon Health and Science University,undefined
[8] University of California San Francisco,undefined
[9] Oregon Health and Science University,undefined
来源：
Genome Medicine | / 5卷
关键词：
Breast Cancer; Lawrence Berkeley National Laboratory; Relapse Event; Affymetrix U133A; Independent Test Dataset;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A robust prognostic signature for hormone-positive node-negative breast cancer
    Griffith, Obi L.
    Pepin, Francois
    Enache, Oana M.
    Heiser, Laura M.
    Collisson, Eric A.
    Spellman, Paul T.
    Gray, Joe W.
    GENOME MEDICINE, 2013, 5
  • [2] Prognostic variables in node-negative and node-positive breast cancer
    Gasparini, G
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 321 - 331
  • [3] Prognostic variables in node-negative and node-positive breast cancer - Introduction
    Giampietro Gasparini
    Breast Cancer Research and Treatment, 1998, 51 : 193 - 194
  • [4] Prognostic variables in node-negative and node-positive breast cancer - Introduction
    Gasparini, G
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 51 (03) : 193 - 194
  • [5] Prognostic variables in node-negative and node-positive breast cancer - editorial
    Giampietro Gasparini
    Breast Cancer Research and Treatment, 1998, 52 : 321 - 331
  • [6] Prediction of Adjuvant Chemotherapy Benefit in Hormone-positive Node-negative Early Breast Cancer Patients by EndoPredict - A Multicentre Pan Indian Study
    Somashekhar, S. P.
    Bahl, Charu
    Dattatreya, Palanki Satya
    Kumar, Rajeev
    Vijay, D. G.
    Zaveri, Shabber
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S561 - S563
  • [7] Chemotherapy use for hormone receptor-positive, node-negative breast cancer
    Hassett, M. J.
    Hughes, M. E.
    Niland, J. C.
    Edge, S. B.
    Theriault, R. L.
    Wong, Y.
    Wilson, J.
    Carter, B. W.
    Blayney, D. W.
    Weeks, J. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] PROGNOSTIC SIGNIFICANCE OF PgR EXPRESSION IN HORMONE-RECEPTOR POSITIVE, HER2-NEGATIVE, NODE-NEGATIVE BREAST CANCER
    Ono, Makiko
    Hitoshi, Tsuda
    Yoshida, Masayuki
    Shimizu, Chikako
    Kinoshita, Takayuki
    Tamura, Kenji
    ANNALS OF ONCOLOGY, 2014, 25
  • [9] A prognostic index for operable, node-negative breast cancer
    M McCallum
    C Baker
    K Gillespie
    B Cohen
    H Stewart
    R Leonard
    D Cameron
    R Leake
    J Paxton
    A Robertson
    C Purdie
    A Gould
    M Steel
    British Journal of Cancer, 2004, 90 : 1933 - 1941
  • [10] PROGNOSTIC INDICATORS IN NODE-NEGATIVE BREAST-CANCER
    WEIL, RJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19): : 1348 - 1348
12345